For consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.

1 June 2010
Chronic pain affects one in five Australians and costs the economy $34 billion per year. Opioids are an option for some patients with chronic pain but there has been a significant increase in the supply of prescription opioids over the last two decades.
The latest NPS therapeutic program, Opioid use in chronic pain: use a planned approach, explores ways of optimising the benefits of opioids in chronic pain while minimising the harms associated with inappropriate use. These include careful patient selection, clear communication about the goals of opioid therapy, careful advice about proper use and close monitoring.
“Opioids are an option for some patients with chronic pain, with their goals being to reduce pain and to improve function and quality of life. However they should only be prescribed as part of a comprehensive pain management plan developed in consultation with the patient,” NPS CEO, Dr Lynn Weekes said.
“Documenting the plan and outlining the terms for opioid use can prevent unsanctioned use and provide pre-agreed approaches if the patient experiences repeated episodes of breakthrough pain. Finally, it can help patients to be realistic about the goals of their treatment,” Dr Weekes said.
Long-acting opioids are recommended for chronic pain and short-acting opioids can be used to establish pain relief requirements. However the choice of opioid, initial dose and titration schedule should be developed in line with the patient’s health, age, response and past experience with opioids.
“In cases of non-specific low back pain, a thorough patient history and physical examination are critical in checking for red flag indicators of potentially serious underlying conditions. In the absence of red flags, imaging tests are not routinely recommended and are unlikely to improve patient outcomes or alter clinical decision-making,” Dr Weekes said.
As part of this program, health professionals are encouraged to:
The following resources have been developed for health professionals:
For further information visit www.nps.org.au/health_professionals.
The National Prescribing Service Limited (NPS) is an independent, not-for-profit organisation for quality use of medicines funded by the Australian Government Department of Health and Ageing.
Media enquiries
Contact us
Date published: 2010-06-01 19:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.